Tuesday, September 1, 2026

HomeGeneral NewsPfizer to launch trial of Omicron-targeted COVID vaccine

Pfizer to launch trial of Omicron-targeted COVID vaccine

- Advertisement -


New York: Pfizer Inc and BioNTech SE said on Wednesday AEDT they started a clinical trial to test a new version of their vaccine specifically designed to target the COVID-19 Omicron variant, which has eluded some of the protection provided by the original two-dose vaccine regimen.

Banking on…



Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed